Cargando…

Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: correspondence

Detalles Bibliográficos
Autores principales:	Mungmunpuntipanjtip, Rujittika, Sriwijitalai, Won, Wiwanitkit, Viroj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430000/ https://www.ncbi.nlm.nih.gov/pubmed/36045269 http://dx.doi.org/10.1007/s10549-022-06719-9

Ejemplares similares

Esophagitis and SARS-CoV-2 vaccine: Correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2023)

SARS-CoV-2 mRNA vaccination, prostate cancer and steroids: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Drug induced hepatitis and SARS-CoV-2 vaccination: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Correspondence on “Lack of vaccination in ventilated patients for SARS-CoV-2 in France”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Seroconversion after Inactive SARS-CoV-2 Vaccination and Obesity: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Central diabetes insipidus, hypophysitis and SARS-CoV-2 vaccine: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Post-SARS-CoV-2 vaccination COVID toes and fingers correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

SARS-CoV-2 infection, vaccination and acquired hemophilia: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Delayed skin reactions and mRNA vaccines against SARS-CoV-2: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Relapse of minimal change disease and inactivated SARS-CoV-2 vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Correspondence on “prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Branch retinal vein occlusion and COVID-19 vaccination: Correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Leukocytoclastic Vasculitis and SARS-COV-2 Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

COVID-19 Vaccination and Cancer: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

COVID-19 Vaccination in Cancer Patients: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Social media campaign and research program to address COVID-19 vaccine hesitancy in pregnancy: correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Subacute thyroiditis and different SARS-CoV-2 vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Deaths associated with newly launched SARS-CoV-2 vaccination
por: Mungmunpuntipamtip, Rujittika, et al.
Publicado: (2021)

Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Attitudes toward a COVID-19 vaccine and vaccination status in cancer patients: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

IL-6 serum level and olfactory dysfunction severity in COVID-19: correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

COVID-19 Vaccine Side Effects among Early-Vaccinated Healthcare Workers: Correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 Vaccination in Hemodialysis Patients Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Correspondence on “Shoulder Injury Related to Vaccine Administration”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Willingness to Pay for a Coronavirus Vaccine: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

SARS-CoV-2 Transmission and Vaginal Delivery
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Correspondence on “Extreme heat and COVID-19 vaccination sites”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Autoimmune hepatitis triggered by COVID-19 vaccination: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Pituitary apoplexy after COVID-19 vaccination: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Pituitary apoplexy after COVID-19 vaccination: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Parsonage–Turner Syndrome and COVID-19 Vaccine: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Antineutrophil cytoplasmic antibody, glomerulonephritis and inactivated SARS‐CoV‐2 vaccine: comment on the article by Garcia et al
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Comment on “immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Cancer care in a time of COVID and telehealth: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Micronutrient supplementation, COVID-19 vaccination and adverse effect: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_280qsidnmvv6qn290cl0rs4ttk